Report Detail
COVID-19 Impact on Global Prescription Arthritis Medications Market Insights, Forecast to 2026
- RnM3984856 |
- 03 June, 2020 |
- Global |
- 116 Pages |
- QYResearch |
- Pharma & Healthcare
Arthritis medicines are generally very effective in helping people with arthritis to manage joint pain and other symptoms.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Prescription Arthritis Medications market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Prescription Arthritis Medications industry.
Based on our recent survey, we have several different scenarios about the Prescription Arthritis Medications YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Prescription Arthritis Medications will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Prescription Arthritis Medications market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Prescription Arthritis Medications market in terms of both revenue and volume.
Players, stakeholders, and other participants in the global Prescription Arthritis Medications market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Sales and Pricing Analyses
Readers are provided with deeper sales analysis and pricing analysis for the global Prescription Arthritis Medications market. As part of sales analysis, the report offers accurate statistics and figures for sales and revenue by region, by each type segment for the period 2015-2026.
In the pricing analysis section of the report, readers are provided with validated statistics and figures for the price by players and price by region for the period 2015-2020 and price by each type segment for the period 2015-2020.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Prescription Arthritis Medications market, covering important regions, viz, North America, Europe, China and Japan. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of sales for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Prescription Arthritis Medications market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Prescription Arthritis Medications market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Prescription Arthritis Medications market.
The following manufacturers are covered in this report:
Abbott
Amgen
Boehringer Ingelheim
Horizon Pharma
Novartis
Pfizer
Regeneron
...
Prescription Arthritis Medications Breakdown Data by Type
Oral
Topical
Prescription Arthritis Medications Breakdown Data by Application
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
1 Study Coverage
- 1.1 Prescription Arthritis Medications Product Introduction
- 1.2 Market Segments
- 1.3 Key Prescription Arthritis Medications Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Prescription Arthritis Medications Market Size Growth Rate by Type
- 1.4.2 Oral
- 1.4.3 Topical
- 1.5 Market by Application
- 1.5.1 Global Prescription Arthritis Medications Market Size Growth Rate by Application
- 1.5.2 Hospital Pharmacies
- 1.5.3 Online Pharmacies
- 1.5.4 Retail Pharmacies
- 1.6 Coronavirus Disease 2019 (Covid-19): Prescription Arthritis Medications Industry Impact
- 1.6.1 How the Covid-19 is Affecting the Prescription Arthritis Medications Industry
- 1.6.1.1 Prescription Arthritis Medications Business Impact Assessment - Covid-19
- 1.6.1.2 Supply Chain Challenges
- 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
- 1.6.2 Market Trends and Prescription Arthritis Medications Potential Opportunities in the COVID-19 Landscape
- 1.6.3 Measures / Proposal against Covid-19
- 1.6.3.1 Government Measures to Combat Covid-19 Impact
- 1.6.3.2 Proposal for Prescription Arthritis Medications Players to Combat Covid-19 Impact
- 1.6.1 How the Covid-19 is Affecting the Prescription Arthritis Medications Industry
- 1.7 Study Objectives
- 1.8 Years Considered
2 Executive Summary
- 2.1 Global Prescription Arthritis Medications Market Size Estimates and Forecasts
- 2.1.1 Global Prescription Arthritis Medications Revenue 2015-2026
- 2.1.2 Global Prescription Arthritis Medications Sales 2015-2026
- 2.2 Prescription Arthritis Medications Market Size by Region: 2020 Versus 2026
- 2.2.1 Global Prescription Arthritis Medications Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global Prescription Arthritis Medications Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Prescription Arthritis Medications Competitor Landscape by Players
- 3.1 Prescription Arthritis Medications Sales by Manufacturers
- 3.1.1 Prescription Arthritis Medications Sales by Manufacturers (2015-2020)
- 3.1.2 Prescription Arthritis Medications Sales Market Share by Manufacturers (2015-2020)
- 3.2 Prescription Arthritis Medications Revenue by Manufacturers
- 3.2.1 Prescription Arthritis Medications Revenue by Manufacturers (2015-2020)
- 3.2.2 Prescription Arthritis Medications Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Prescription Arthritis Medications Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Prescription Arthritis Medications Revenue in 2019
- 3.2.5 Global Prescription Arthritis Medications Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Prescription Arthritis Medications Price by Manufacturers
- 3.4 Prescription Arthritis Medications Manufacturing Base Distribution, Product Types
- 3.4.1 Prescription Arthritis Medications Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Prescription Arthritis Medications Product Type
- 3.4.3 Date of International Manufacturers Enter into Prescription Arthritis Medications Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
- 4.1 Global Prescription Arthritis Medications Market Size by Type (2015-2020)
- 4.1.1 Global Prescription Arthritis Medications Sales by Type (2015-2020)
- 4.1.2 Global Prescription Arthritis Medications Revenue by Type (2015-2020)
- 4.1.3 Prescription Arthritis Medications Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Prescription Arthritis Medications Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Prescription Arthritis Medications Sales Forecast by Type (2021-2026)
- 4.2.2 Global Prescription Arthritis Medications Revenue Forecast by Type (2021-2026)
- 4.2.3 Prescription Arthritis Medications Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Prescription Arthritis Medications Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Application (2015-2026)
- 5.1 Global Prescription Arthritis Medications Market Size by Application (2015-2020)
- 5.1.1 Global Prescription Arthritis Medications Sales by Application (2015-2020)
- 5.1.2 Global Prescription Arthritis Medications Revenue by Application (2015-2020)
- 5.1.3 Prescription Arthritis Medications Price by Application (2015-2020)
- 5.2 Prescription Arthritis Medications Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Prescription Arthritis Medications Sales Forecast by Application (2021-2026)
- 5.2.2 Global Prescription Arthritis Medications Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Prescription Arthritis Medications Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America Prescription Arthritis Medications by Country
- 6.1.1 North America Prescription Arthritis Medications Sales by Country
- 6.1.2 North America Prescription Arthritis Medications Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America Prescription Arthritis Medications Market Facts & Figures by Type
- 6.3 North America Prescription Arthritis Medications Market Facts & Figures by Application
7 Europe
- 7.1 Europe Prescription Arthritis Medications by Country
- 7.1.1 Europe Prescription Arthritis Medications Sales by Country
- 7.1.2 Europe Prescription Arthritis Medications Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Prescription Arthritis Medications Market Facts & Figures by Type
- 7.3 Europe Prescription Arthritis Medications Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific Prescription Arthritis Medications by Region
- 8.1.1 Asia Pacific Prescription Arthritis Medications Sales by Region
- 8.1.2 Asia Pacific Prescription Arthritis Medications Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific Prescription Arthritis Medications Market Facts & Figures by Type
- 8.3 Asia Pacific Prescription Arthritis Medications Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America Prescription Arthritis Medications by Country
- 9.1.1 Latin America Prescription Arthritis Medications Sales by Country
- 9.1.2 Latin America Prescription Arthritis Medications Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America Prescription Arthritis Medications Market Facts & Figures by Type
- 9.3 Central & South America Prescription Arthritis Medications Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa Prescription Arthritis Medications by Country
- 10.1.1 Middle East and Africa Prescription Arthritis Medications Sales by Country
- 10.1.2 Middle East and Africa Prescription Arthritis Medications Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 U.A.E
- 10.2 Middle East and Africa Prescription Arthritis Medications Market Facts & Figures by Type
- 10.3 Middle East and Africa Prescription Arthritis Medications Market Facts & Figures by Application
11 Company Profiles
- 11.1 Abbott
- 11.1.1 Abbott Corporation Information
- 11.1.2 Abbott Description, Business Overview and Total Revenue
- 11.1.3 Abbott Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Abbott Prescription Arthritis Medications Products Offered
- 11.1.5 Abbott Recent Development
- 11.2 Amgen
- 11.2.1 Amgen Corporation Information
- 11.2.2 Amgen Description, Business Overview and Total Revenue
- 11.2.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
- 11.2.4 Amgen Prescription Arthritis Medications Products Offered
- 11.2.5 Amgen Recent Development
- 11.3 Boehringer Ingelheim
- 11.3.1 Boehringer Ingelheim Corporation Information
- 11.3.2 Boehringer Ingelheim Description, Business Overview and Total Revenue
- 11.3.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
- 11.3.4 Boehringer Ingelheim Prescription Arthritis Medications Products Offered
- 11.3.5 Boehringer Ingelheim Recent Development
- 11.4 Horizon Pharma
- 11.4.1 Horizon Pharma Corporation Information
- 11.4.2 Horizon Pharma Description, Business Overview and Total Revenue
- 11.4.3 Horizon Pharma Sales, Revenue and Gross Margin (2015-2020)
- 11.4.4 Horizon Pharma Prescription Arthritis Medications Products Offered
- 11.4.5 Horizon Pharma Recent Development
- 11.5 Novartis
- 11.5.1 Novartis Corporation Information
- 11.5.2 Novartis Description, Business Overview and Total Revenue
- 11.5.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
- 11.5.4 Novartis Prescription Arthritis Medications Products Offered
- 11.5.5 Novartis Recent Development
- 11.6 Pfizer
- 11.6.1 Pfizer Corporation Information
- 11.6.2 Pfizer Description, Business Overview and Total Revenue
- 11.6.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
- 11.6.4 Pfizer Prescription Arthritis Medications Products Offered
- 11.6.5 Pfizer Recent Development
- 11.7 Regeneron
- 11.7.1 Regeneron Corporation Information
- 11.7.2 Regeneron Description, Business Overview and Total Revenue
- 11.7.3 Regeneron Sales, Revenue and Gross Margin (2015-2020)
- 11.7.4 Regeneron Prescription Arthritis Medications Products Offered
- 11.7.5 Regeneron Recent Development
- 11.1 Abbott
- 11.1.1 Abbott Corporation Information
- 11.1.2 Abbott Description, Business Overview and Total Revenue
- 11.1.3 Abbott Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Abbott Prescription Arthritis Medications Products Offered
- 11.1.5 Abbott Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 Prescription Arthritis Medications Market Estimates and Projections by Region
- 12.1.1 Global Prescription Arthritis Medications Sales Forecast by Regions 2021-2026
- 12.1.2 Global Prescription Arthritis Medications Revenue Forecast by Regions 2021-2026
- 12.2 North America Prescription Arthritis Medications Market Size Forecast (2021-2026)
- 12.2.1 North America: Prescription Arthritis Medications Sales Forecast (2021-2026)
- 12.2.2 North America: Prescription Arthritis Medications Revenue Forecast (2021-2026)
- 12.2.3 North America: Prescription Arthritis Medications Market Size Forecast by Country (2021-2026)
- 12.3 Europe Prescription Arthritis Medications Market Size Forecast (2021-2026)
- 12.3.1 Europe: Prescription Arthritis Medications Sales Forecast (2021-2026)
- 12.3.2 Europe: Prescription Arthritis Medications Revenue Forecast (2021-2026)
- 12.3.3 Europe: Prescription Arthritis Medications Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific Prescription Arthritis Medications Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: Prescription Arthritis Medications Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: Prescription Arthritis Medications Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: Prescription Arthritis Medications Market Size Forecast by Region (2021-2026)
- 12.5 Latin America Prescription Arthritis Medications Market Size Forecast (2021-2026)
- 12.5.1 Latin America: Prescription Arthritis Medications Sales Forecast (2021-2026)
- 12.5.2 Latin America: Prescription Arthritis Medications Revenue Forecast (2021-2026)
- 12.5.3 Latin America: Prescription Arthritis Medications Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa Prescription Arthritis Medications Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: Prescription Arthritis Medications Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: Prescription Arthritis Medications Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: Prescription Arthritis Medications Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter’s Five Forces Analysis
- 13.5 Primary Interviews with Key Prescription Arthritis Medications Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Prescription Arthritis Medications Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
Summary:
Get latest Market Research Reports on COVID-19 Impact on Global Prescription Arthritis Medications. Industry analysis & Market Report on COVID-19 Impact on Global Prescription Arthritis Medications is a syndicated market report, published as COVID-19 Impact on Global Prescription Arthritis Medications Market Insights, Forecast to 2026. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global Prescription Arthritis Medications market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
